| SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues | Cell | 2020 | 1.3K |
| Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment | Cell | 2020 | 558 |
| SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells | EMBO Journal | 2020 | 538 |
| Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer | Journal of Clinical Oncology | 2020 | 298 |
| The future of cystic fibrosis care: a global perspective | Lancet Respiratory Medicine,the | 2020 | 259 |
| Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial | International Journal of Cancer | 2020 | 125 |
| Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD | New England Journal of Medicine | 2020 | 121 |
| Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis | Nature Communications | 2020 | 106 |
| Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA. | Journal of Clinical Oncology | 2020 | 87 |
| Ambient air pollution and depression: A systematic review with meta-analysis up to 2019 | Science of the Total Environment | 2020 | 84 |
| Ambient air pollution and diabetes: A systematic review and meta-analysis | Environmental Research | 2020 | 79 |
| MSC Based Therapies-New Perspectives for the Injured Lung | Journal of Clinical Medicine | 2020 | 74 |
| Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study | American Journal of Respiratory and Critical Care Medicine | 2020 | 72 |
| Tumor-derived exosomes in the regulation of macrophage polarization | Inflammation Research | 2020 | 70 |
| Challenges in lung cancer therapy during the COVID-19 pandemic | Lancet Respiratory Medicine,the | 2020 | 62 |
| Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: CHEST Guideline and Expert Panel Report | Chest | 2020 | 62 |
| Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma | Nature Medicine | 2020 | 62 |
| SARS-CoV-2 antibody testing-questions to be asked | Journal of Allergy and Clinical Immunology | 2020 | 60 |
| Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications | American Journal of Respiratory and Critical Care Medicine | 2020 | 57 |
| The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis | Pulmonary Medicine | 2020 | 56 |
| Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial | Lancet Oncology, The | 2020 | 54 |
| Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial | Annals of Oncology | 2020 | 54 |
| Defining the Adult Neural Stem Cell Niche Proteome Identifies Key Regulators of Adult Neurogenesis | Cell Stem Cell | 2020 | 54 |
| ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer | ESMO Open | 2020 | 54 |
| EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma | Allergy: European Journal of Allergy and Clinical Immunology | 2020 | 53 |
